Giudice LC. Endometriosis. N Engl J Med. 2010;362(25):2389–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willett WC, Hunter DJ. Reproductive history and endometriosis among premenopausal women. Obstet Gynecol. 2004;104(5 Pt 1):965–74.

Article  PubMed  Google Scholar 

Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–79.

Article  CAS  PubMed  Google Scholar 

Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–9.

Article  CAS  PubMed  Google Scholar 

Johnson NP, Hummelshoj L. World Endometriosis Society Montpellier C: consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–68.

Article  PubMed  Google Scholar 

Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–56.

Article  CAS  PubMed  Google Scholar 

Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de CiccoNardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT. World Endometriosis Research Foundation Global Study of Women’s Health c: impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366-373 e368.

Article  PubMed  PubMed Central  Google Scholar 

Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292–9.

Article  PubMed  Google Scholar 

Soliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712–22.

Article  PubMed  Google Scholar 

Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Economic burden of endometriosis. Fertil Steril. 2006;86(6):1561–72.

Article  PubMed  Google Scholar 

Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S. Estrogen production and metabolism in endometriosis. Ann NY Acad Sci. 2002;955:75–85 (discussion 86–78, 396–406).

Article  CAS  PubMed  Google Scholar 

Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1992;166(2):740–5.

Article  CAS  PubMed  Google Scholar 

Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12.

Article  CAS  PubMed  Google Scholar 

Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010;12:CD008475.

Google Scholar 

Practice Committee of American Society for Reproductive M. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90(5 Suppl):S260-269.

Google Scholar 

Donnez J, Chantraine F, Nisolle M. The efficacy of medical and surgical treatment of endometriosis-associated infertility: arguments in favour of a medico-surgical approach. Hum Reprod Update. 2002;8(1):89–94.

Article  PubMed  Google Scholar 

Donnez O, Roman H. Choosing the right surgical technique for deep endometriosis: shaving, disc excision, or bowel resection? Fertil Steril. 2017;108(6):931–42.

Article  PubMed  Google Scholar 

Koga K, Takamura M, Fujii T, Osuga Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104(4):793–801.

Article  PubMed  Google Scholar 

Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet. 2001;358(9295):1793–803.

Article  CAS  PubMed  Google Scholar 

Betz SF, Zhu YF, Chen C, Struthers RS. Non-peptide gonadotropin-releasing hormone receptor antagonists. J Med Chem. 2008;51(12):3331–48.

Article  CAS  PubMed  Google Scholar 

Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, et al. Treatment of endometriosis-associated pain with Elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28–40.

Article  CAS  PubMed  Google Scholar 

Diamond MP, Carr B, Dmowski WP, Koltun W, O’Brien C, Jiang P, Burke J, Jimenez R, Garner E, Chwalisz K. Elagolix treatment for endometriosis-associated pain: results from a Phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014;21(3):363–71.

Article  PubMed  Google Scholar 

Giudice LC, As-Sanie S, Arjona Ferreira JC, Becker CM, Abrao MS, Lessey BA, Brown E, Dynowski K, Wilk K, Li Y, et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate Phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet. 2022;399(10343):2267–79.

Article  CAS  PubMed  Google Scholar 

Xu Y, Hu W, Li J, Jiang X, Shi P, Shen K, Shen Y, Ma L, Cao Y. Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women. Front Pharmacol. 2022;13:1027648.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen J, Swift B, Mamelok R, Pine S, Sinclair J, Attar M. Design and conduct considerations for first-in-human trials. Clin Transl Sci. 2019;12(1):6–19.

Article  PubMed  Google Scholar 

Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, et al. Long-term outcomes of elagolix in women with endometriosis: results from two extension studies. Obstet Gynecol. 2018;132(1):147–60.

Article  CAS  PubMed  Google Scholar 

Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2021;115(2):397–405.

Article  CAS  PubMed  Google Scholar 

Struthers RS, Nicholls AJ, Grundy J, Chen T, Jimenez R, Yen SS, Bozigian HP. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J Clin Endocrinol Metab. 2009;94(2):545–51.

Article  CAS  PubMed  Google Scholar 

Ng J, Chwalisz K, Carter DC, Klein CE. Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women. J Clin Endocrinol Metab. 2017;102(5):1683–91.

Article  PubMed  Google Scholar 

Winzenborg I, Nader A, Polepally AR, Liu M, Degner J, Klein CE, Mostafa NM, Noertersheuser P, Ng J. Population pharmacokinetics of elagolix in healthy women and women with endometriosis. Clin Pharmacokinet. 2018;57(10):1295–306.

Article  CAS  PubMed  Google Scholar